TOMI™ Environmental Solutions Retains IMS Investor Relations

FREDERICK, Md., Nov. 24, 2020 (GLOBE NEWSWIRE) -- TOMI^™ Environmental Solutions, Inc. (“TOMI”) (NASDAQ: TOMZ) is a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products – a hydrogen peroxide-based mist and fog comprised of ionized Hydrogen Peroxide (iHP) - today announced the retention of IMS Investor Relations to develop and execute a comprehensive investor relations and financial communications program.

Halden S. Shane, Chief Executive Officer, stated, “Over the past year we have seen a dramatic acceleration in the adoption of our technology and we are making considerable strides building the business for sustainable growth. With our recent uplisting to NASDAQ, we thought the time was right to establish an enhanced investor relations program. We look forward to working with IMS Investor Relations to proactively communicate TOMI’s progress to the broader investment community as we look to build long-term value for our shareholders.”

John G. Nesbett, Founder and President of IMS Investor Relations, stated, “TOMI is at an exciting point in its growth as both existing and new customers increasingly utilize the Company’s proprietary disinfection and decontamination solutions. This progress is evidenced by nine-month 2020 revenue growth to $21.4 million from $4.5 million last year and the achievement of strong profitability. Their patented SteraMist Technology is becoming the gold standard solution for sterilization across multiple sectors, including Healthcare, Community (Schools, Senior Centers), Life Sciences, Food Safety and Commercial. We look forward to working closely with management and leveraging our expertise to help convey TOMI’s unique value proposition to Wall Street as the Company scales its business.”

About IMS Investor Relations

IMS Investor Relations () helps small to mid-sized public companies ensure their public listing is a vital strategic asset with a credible and resonating brand, aligned shareholders and a valuation reflective of the long-term value of the business. IMS was founded to shine a much-needed light on microcap to mid-cap companies, a sector that is often misunderstood, underfollowed and undervalued by Wall Street. The firm’s vast expertise in this space, trusted reputation and extensive relationships with analysts, institutional investors, family offices and brokers opens doors often kept closed to others. IMS prides itself on its longstanding client relationships due to its ability to understand its clients’ needs and its agility in addressing the challenges of today’s ever evolving financial landscape.

About TOMI™ Environmental Solutions, Inc.

TOMI^™ Environmental Solutions, Inc. (NASDAQ:) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology^® (BIT^™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT^™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP^™). Represented by the SteraMist^® brand of products, iHP^™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

For Investor Relations Inquiries:



TOMI^™ Environmental Solutions Contact:

Harold Paul

IMS Investor Relations Contact:

John Nesbett/Jennifer Belodeau

(203) 972-9200